Assyro AI

FDA Orange Book · active-ingredient family

Pyridoxine hydrochloride

Pyridoxine hydrochloride is approved in 11 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

0

Brand (NDA)

11

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Generic (ANDA) products (11)

ProductApplicantApplicationTEApproved
PYRIDOXINE HYDROCHLORIDEMYLAN INSTITUTIONALANDA 204879Jul 14, 2016
PYRIDOXINE HYDROCHLORIDEEPIC PHARMA LLCANDA 087967Oct 01, 1982
HEXA-BETALINLILLYANDA 080854Approved Prior to Jan 1, 1982
PYRIDOXINE HYDROCHLORIDEBEL MARANDA 080761Approved Prior to Jan 1, 1982
PYRIDOXINE HYDROCHLORIDEDELL LABSANDA 083771Approved Prior to Jan 1, 1982
PYRIDOXINE HYDROCHLORIDEDELL LABSANDA 083772Approved Prior to Jan 1, 1982
PYRIDOXINE HYDROCHLORIDEDR REDDYSANDA 080572Approved Prior to Jan 1, 1982
PYRIDOXINE HYDROCHLORIDEELKINS SINNANDA 080581Approved Prior to Jan 1, 1982
PYRIDOXINE HYDROCHLORIDERLDFRESENIUS KABI USAANDA 080618Approved Prior to Jan 1, 1982
PYRIDOXINE HYDROCHLORIDELUITPOLDANDA 080669Approved Prior to Jan 1, 1982
PYRIDOXINE HYDROCHLORIDEWATSON LABSANDA 083760Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Pyridoxine hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.